Acutaas Chemicals: Completion of the Acquisition of the shares of the Step-down Subsidiary - Enchem Ami Organics Private…

What happened

Acutaas Chemicals (ACUTAAS) filed a disclosure with the exchanges on 17 October 2026 at 03:08 PM titled "Completion of the Acquisition of the shares of the Step-down Subsidiary - Enchem Ami Organics Private Limited as per details attached".

Company snapshot

Acutaas Chemicals is a small-cap company in the Healthcare sector, with a market value of about ₹26,248 crore.

The stock last traded at ₹3,206, against a 52-week range of ₹1,551–₹3,740 (14.3% below the high).

Before this filing the shares had moved −6.3% over the month and −14.3% over three months. Average daily turnover over the last 20 sessions was about ₹108 crore.

Promoters held 32.66% at the end of Q1 FY27. Foreign institutions owned 21.61% and domestic institutions 19.56%.

What history shows

This is not the company's first m&a disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.

Across 146 similar disclosures by other Healthcare companies, shares moved +0.7% on average the next day and +0.9% over five days; 58% of them rose the next day.

Market-wide, 2,112 m&a filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 49% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• Regulatory approvals, completion of the deal and its effect on revenue and margins.

In the news

Recent coverage elsewhere (links open the original publisher):

• Acutaas Chemicals (ACUTAAS) Share/Stock Price Live, NSE — TechGraph, 9 Oct 2026
• Acutaas Chemicals Limited: Completes 100% Acquisition of Enchem Ami Organics — InvestyWise, 17 Oct 2026

Source

• Exchange filing (PDF)